212 related articles for article (PubMed ID: 32182396)
1. Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic Sclerosis.
Zhang Y; Zhu H; Layritz F; Luo H; Wohlfahrt T; Chen CW; Soare A; Bergmann C; Ramming A; Groeber F; Reuter C; Fornasini G; Soukhareva N; Schreiber B; Ramamurthy S; Amann K; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Aug; 72(8):1385-1395. PubMed ID: 32182396
[TBL] [Abstract][Full Text] [Related]
2. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
Hasegawa T; Utsunomiya A; Chino T; Kasamatsu H; Shimizu T; Matsushita T; Obara T; Ishii N; Ogasawara H; Ikeda W; Imai T; Oyama N; Hasegawa M
Arthritis Res Ther; 2024 May; 26(1):94. PubMed ID: 38702742
[TBL] [Abstract][Full Text] [Related]
3. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C
Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630
[TBL] [Abstract][Full Text] [Related]
5. Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.
Huang J; Maier C; Zhang Y; Soare A; Dees C; Beyer C; Harre U; Chen CW; Distler O; Schett G; Wollin L; Distler JHW
Ann Rheum Dis; 2017 Nov; 76(11):1941-1948. PubMed ID: 28814429
[TBL] [Abstract][Full Text] [Related]
6. Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis.
Mor A; Segal Salto M; Katav A; Barashi N; Edelshtein V; Manetti M; Levi Y; George J; Matucci-Cerinic M
Ann Rheum Dis; 2019 Sep; 78(9):1260-1268. PubMed ID: 31129606
[TBL] [Abstract][Full Text] [Related]
7. Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease.
Liu C; Yang X; Zhu P; Fujino M; Ito H; Takahashi K; Nakajima M; Tanaka T; Wang J; Zhuang J; Zou H; Li XK
Exp Dermatol; 2018 Oct; 27(10):1104-1111. PubMed ID: 29978518
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β plays divergent roles in modulating vascular remodeling, inflammation, and pulmonary fibrosis in a murine model of scleroderma.
Tsujino K; Reed NI; Atakilit A; Ren X; Sheppard D
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L22-L31. PubMed ID: 27864286
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyopathy in murine models of systemic sclerosis.
Venalis P; Kumánovics G; Schulze-Koops H; Distler A; Dees C; Zerr P; Palumbo-Zerr K; Czirják L; Mackevic Z; Lundberg IE; Distler O; Schett G; Distler JH
Arthritis Rheumatol; 2015 Feb; 67(2):508-16. PubMed ID: 25371068
[TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Miura S; Toyama T; Takahashi T; Ichimura Y; Yoshizaki A; Trojanowska M; Sato S
J Invest Dermatol; 2017 Mar; 137(3):631-640. PubMed ID: 27777101
[TBL] [Abstract][Full Text] [Related]
12. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Zhang Y; McCormick LL; Gilliam AC
J Invest Dermatol; 2003 Oct; 121(4):713-9. PubMed ID: 14632186
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
14. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
McCormick LL; Zhang Y; Tootell E; Gilliam AC
J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100
[TBL] [Abstract][Full Text] [Related]
15. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis.
Bagnato G; Bitto A; Pizzino G; Irrera N; Sangari D; Cinquegrani M; Roberts WN; Matucci Cerinic M; Squadrito F; Altavilla D; Bagnato G; Saitta A
Rheumatology (Oxford); 2013 Aug; 52(8):1377-86. PubMed ID: 23620550
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F
Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130
[TBL] [Abstract][Full Text] [Related]
18. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
Nakai K; Karita S; Igarashi J; Tsukamoto I; Hirano K; Kubota Y
J Dermatol Sci; 2019 Apr; 94(1):205-212. PubMed ID: 30954335
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX
Luong VH; Utsunomiya A; Chino T; Doanh LH; Matsushita T; Obara T; Kuboi Y; Ishii N; Machinaga A; Ogasawara H; Ikeda W; Kawano T; Imai T; Oyama N; Hasegawa M
Arthritis Rheumatol; 2019 Nov; 71(11):1923-1934. PubMed ID: 31173491
[TBL] [Abstract][Full Text] [Related]
20. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]